SMO and ameloblastoma: More recent understanding of the biological factors shows that ameloblastomas arising from the mandible are likely to be associated with mutations in the MAPK pathway, with BRAFV600E mutations being the most common, while those arising from the maxilla tend to have SMO mutations [10–13].